Day Trading Stocks & Futures
- Thread starter TraderRavi
- Start date
- Tags banknifty bnf daytrading nifty future
Diplomatic dispute between Germany and the United States
Meanwhile, there are apparently disputes between Germany and the United States over a Tübingen company that is working on a vaccine against the coronavirus. According to a report by "Welt am Sonntag", US President Donald Trump is trying to lure German scientists to America with high financial donations or to secure the drug exclusively for his country, the newspaper citing government circles in Berlin.
The US President allegedly offers the company a large amount to secure its work exclusively. Trump is doing everything possible to get a vaccine for the United States. "But only for the United States," according to the newspaper, according to the federal government.
(Comment from me: How selfish must a person be to only think like this in those times where such a vaccine is needed for the whole world. This men is really a huge axxxxxxxxxxe and has lost now my whole respect in any way after I see this.
)
At the request of the German Press Agency, the Federal Ministry of Health referred to statements that a ministry spokesman had already made to "Welt am Sonntag". "The federal government is very interested in the fact that vaccines and active substances against the novel corona virus are also being developed in Germany and Europe," the newspaper quoted the spokesman. "In this regard, the government is in intensive contact with the company CureVac."
Germany, according to the newspaper, is trying to keep the company with financial offers. According to the report, CureVac is working with the federal Paul Ehrlich Institute for Vaccines and Biomedical Drugs to produce a vaccine against the virus.
The full article you would find here, but its written in German: https://www.spiegel.de/politik/ausl...fallen-a-04fd8425-d9ca-417c-a677-aa74e4b4b022
And here the company we talk about: https://www.curevac.com/about-curevac
CureVac CEO replaced in midst of biotech's coronavirus push
At the Mar. 2 White House meeting, Menichella told President Trump that CureVac expects to start a Phase 1 study in June, an effort helped by its partnership with CEPI.
"We believe we can develop the vaccine for COVID-19 very, very quickly, and we have the wherewithal to manufacture it, although we would like some additional help on our largest GMP fourth facility," Menichella said.
Source: https://www.biopharmadive.com/news/curevac-coronavirus-replace-ceo-menichella/574015/
DP
Meanwhile, there are apparently disputes between Germany and the United States over a Tübingen company that is working on a vaccine against the coronavirus. According to a report by "Welt am Sonntag", US President Donald Trump is trying to lure German scientists to America with high financial donations or to secure the drug exclusively for his country, the newspaper citing government circles in Berlin.
The US President allegedly offers the company a large amount to secure its work exclusively. Trump is doing everything possible to get a vaccine for the United States. "But only for the United States," according to the newspaper, according to the federal government.
(Comment from me: How selfish must a person be to only think like this in those times where such a vaccine is needed for the whole world. This men is really a huge axxxxxxxxxxe and has lost now my whole respect in any way after I see this.
)At the request of the German Press Agency, the Federal Ministry of Health referred to statements that a ministry spokesman had already made to "Welt am Sonntag". "The federal government is very interested in the fact that vaccines and active substances against the novel corona virus are also being developed in Germany and Europe," the newspaper quoted the spokesman. "In this regard, the government is in intensive contact with the company CureVac."
Germany, according to the newspaper, is trying to keep the company with financial offers. According to the report, CureVac is working with the federal Paul Ehrlich Institute for Vaccines and Biomedical Drugs to produce a vaccine against the virus.
The full article you would find here, but its written in German: https://www.spiegel.de/politik/ausl...fallen-a-04fd8425-d9ca-417c-a677-aa74e4b4b022
And here the company we talk about: https://www.curevac.com/about-curevac
CureVac CEO replaced in midst of biotech's coronavirus push
At the Mar. 2 White House meeting, Menichella told President Trump that CureVac expects to start a Phase 1 study in June, an effort helped by its partnership with CEPI.
"We believe we can develop the vaccine for COVID-19 very, very quickly, and we have the wherewithal to manufacture it, although we would like some additional help on our largest GMP fourth facility," Menichella said.
Source: https://www.biopharmadive.com/news/curevac-coronavirus-replace-ceo-menichella/574015/
DP
https://amp.dw.com/en/germany-and-us-wrestle-over-coronavirus-vaccine-report/a-52777990
By june july they say this year
By june july they say this year
Diplomatic dispute between Germany and the United States
Meanwhile, there are apparently disputes between Germany and the United States over a Tübingen company that is working on a vaccine against the coronavirus. According to a report by "Welt am Sonntag", US President Donald Trump is trying to lure German scientists to America with high financial donations or to secure the drug exclusively for his country, the newspaper citing government circles in Berlin.
The US President allegedly offers the company a large amount to secure its work exclusively. Trump is doing everything possible to get a vaccine for the United States. "But only for the United States," according to the newspaper, according to the federal government.
(Comment from me: How selfish must a person be to only think like this in those times where such a vaccine is needed for the whole world. This men is really a huge axxxxxxxxxxe and has lost now my whole respect in any way after I see this.)
At the request of the German Press Agency, the Federal Ministry of Health referred to statements that a ministry spokesman had already made to "Welt am Sonntag". "The federal government is very interested in the fact that vaccines and active substances against the novel corona virus are also being developed in Germany and Europe," the newspaper quoted the spokesman. "In this regard, the government is in intensive contact with the company CureVac."
Germany, according to the newspaper, is trying to keep the company with financial offers. According to the report, CureVac is working with the federal Paul Ehrlich Institute for Vaccines and Biomedical Drugs to produce a vaccine against the virus.
The full article you would find here, but its written in German: https://www.spiegel.de/politik/ausl...fallen-a-04fd8425-d9ca-417c-a677-aa74e4b4b022
And here the company we talk about: https://www.curevac.com/about-curevac
CureVac CEO replaced in midst of biotech's coronavirus push
At the Mar. 2 White House meeting, Menichella told President Trump that CureVac expects to start a Phase 1 study in June, an effort helped by its partnership with CEPI.
"We believe we can develop the vaccine for COVID-19 very, very quickly, and we have the wherewithal to manufacture it, although we would like some additional help on our largest GMP fourth facility," Menichella said.
Source: https://www.biopharmadive.com/news/curevac-coronavirus-replace-ceo-menichella/574015/
DP
Meanwhile, there are apparently disputes between Germany and the United States over a Tübingen company that is working on a vaccine against the coronavirus. According to a report by "Welt am Sonntag", US President Donald Trump is trying to lure German scientists to America with high financial donations or to secure the drug exclusively for his country, the newspaper citing government circles in Berlin.
The US President allegedly offers the company a large amount to secure its work exclusively. Trump is doing everything possible to get a vaccine for the United States. "But only for the United States," according to the newspaper, according to the federal government.
(Comment from me: How selfish must a person be to only think like this in those times where such a vaccine is needed for the whole world. This men is really a huge axxxxxxxxxxe and has lost now my whole respect in any way after I see this.
)At the request of the German Press Agency, the Federal Ministry of Health referred to statements that a ministry spokesman had already made to "Welt am Sonntag". "The federal government is very interested in the fact that vaccines and active substances against the novel corona virus are also being developed in Germany and Europe," the newspaper quoted the spokesman. "In this regard, the government is in intensive contact with the company CureVac."
Germany, according to the newspaper, is trying to keep the company with financial offers. According to the report, CureVac is working with the federal Paul Ehrlich Institute for Vaccines and Biomedical Drugs to produce a vaccine against the virus.
The full article you would find here, but its written in German: https://www.spiegel.de/politik/ausl...fallen-a-04fd8425-d9ca-417c-a677-aa74e4b4b022
And here the company we talk about: https://www.curevac.com/about-curevac
CureVac CEO replaced in midst of biotech's coronavirus push
At the Mar. 2 White House meeting, Menichella told President Trump that CureVac expects to start a Phase 1 study in June, an effort helped by its partnership with CEPI.
"We believe we can develop the vaccine for COVID-19 very, very quickly, and we have the wherewithal to manufacture it, although we would like some additional help on our largest GMP fourth facility," Menichella said.
Source: https://www.biopharmadive.com/news/curevac-coronavirus-replace-ceo-menichella/574015/
DP
IDFC First to invest ₹250 crore in Yes Bank
IDFC First Bank on Sunday said it will make an equity investment of ₹250 crore in beleaguered Yes Bank to acquire 25 crore equity shares.
"...duly authorized committee of the Board of Directors of IDFC FIRST Bank Ltd had at its meeting held on March 14, 2020 accorded approval for an equity investment of upto ₹250 crores comprising upto 25 crore equity shares at a price of ₹10 each and face value of ₹2 each, under the proposed Scheme of Reconstruction of Yes Bank Ltd under the Banking Regulation Act, 1949, subject to regulatory and government approval(s), if any," the bank said in a BSE filing.
Earlier on Saturday, Federal Bank had committed to investing ₹300 crore in Yes Bank for subscription of its 30 crore shares.
Under the plan, state-run SBI will infuse ₹7,250 crore in the crisis-ridden bank and take 49% equity.
As per the rescue plan, ICICI Bank will invest ₹1,000 crore, mortgage lender HDFC ₹1,000 crore, Axis Bank ₹600 crore, Kotak Mahindra Bank ₹500 crore, Bandhan Bank and Federal Bank ₹300 crore each.
There will be a three year lock-in period for all the investors. However, the lock-in period for SBI would be only for 26 per cent of shareholding. It would be 75 per cent in case of other investors.
https://www.livemint.com
IDFC First Bank on Sunday said it will make an equity investment of ₹250 crore in beleaguered Yes Bank to acquire 25 crore equity shares.
"...duly authorized committee of the Board of Directors of IDFC FIRST Bank Ltd had at its meeting held on March 14, 2020 accorded approval for an equity investment of upto ₹250 crores comprising upto 25 crore equity shares at a price of ₹10 each and face value of ₹2 each, under the proposed Scheme of Reconstruction of Yes Bank Ltd under the Banking Regulation Act, 1949, subject to regulatory and government approval(s), if any," the bank said in a BSE filing.
Earlier on Saturday, Federal Bank had committed to investing ₹300 crore in Yes Bank for subscription of its 30 crore shares.
Under the plan, state-run SBI will infuse ₹7,250 crore in the crisis-ridden bank and take 49% equity.
As per the rescue plan, ICICI Bank will invest ₹1,000 crore, mortgage lender HDFC ₹1,000 crore, Axis Bank ₹600 crore, Kotak Mahindra Bank ₹500 crore, Bandhan Bank and Federal Bank ₹300 crore each.
There will be a three year lock-in period for all the investors. However, the lock-in period for SBI would be only for 26 per cent of shareholding. It would be 75 per cent in case of other investors.
https://www.livemint.com
Similar threads
-
-
Collective Investment Scheme in stocks and futures trading?
- Started by rakamaka
- Replies: 7
-
Trading Futures: Indices Vs Individual Stocks- Started by Trade_Artist
- Replies: 9
-
-